用益生菌唾液链球菌BIO5菌株制备的酸奶控制儿童细菌性扁桃体炎

Q4 Medicine

International Journal of Probiotics and Prebiotics Pub Date : 2020-08-06 DOI:10.37290/ijpp2641-7197.15:30-33

V. Fantinato, Heloísa Ramalho de Carvalho, Ana Lucia Orlandini Pilleggi de Sousa

{"title":"用益生菌唾液链球菌BIO5菌株制备的酸奶控制儿童细菌性扁桃体炎","authors":"V. Fantinato, Heloísa Ramalho de Carvalho, Ana Lucia Orlandini Pilleggi de Sousa","doi":"10.37290/ijpp2641-7197.15:30-33","DOIUrl":null,"url":null,"abstract":"This double-blinded study aims to verify whether the yogurt prepared with a Streptococcus salivarius BIO5 probiotic strain can control recurrent tonsillitis in children. To this end, children with recurrent Streptococcus pyogenes tonsillitis consumed one of the two yogurt preparations daily for one year. The placebo group received the yogurt prepared with normal yogurt bacteria (Streptococcus thermophilus and Lactobacillus bulgaricus) whereas the treatment group received the yogurt prepared with the S. salivarius subsp. salivarius BIO5 strain. In the children completing the study, the recurrence of tonsillitis was about 89% in the placebo vs. about 12% in the treatment group. Furthermore, the children who dropped out from the treatment group showed about 3 times higher rate of infection. These data support the prevention of bacterial tonsillitis in children by daily consumption of the yogurt prepared with the BIO5 Streptococcus salivarius probiotic.","PeriodicalId":53704,"journal":{"name":"International Journal of Probiotics and Prebiotics","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Use of Yogurt Prepared with the Probiotic Streptococcus Salivarius BIO5 Strain in the Control of Bacterial Tonsillitis in Children\",\"authors\":\"V. Fantinato, Heloísa Ramalho de Carvalho, Ana Lucia Orlandini Pilleggi de Sousa\",\"doi\":\"10.37290/ijpp2641-7197.15:30-33\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This double-blinded study aims to verify whether the yogurt prepared with a Streptococcus salivarius BIO5 probiotic strain can control recurrent tonsillitis in children. To this end, children with recurrent Streptococcus pyogenes tonsillitis consumed one of the two yogurt preparations daily for one year. The placebo group received the yogurt prepared with normal yogurt bacteria (Streptococcus thermophilus and Lactobacillus bulgaricus) whereas the treatment group received the yogurt prepared with the S. salivarius subsp. salivarius BIO5 strain. In the children completing the study, the recurrence of tonsillitis was about 89% in the placebo vs. about 12% in the treatment group. Furthermore, the children who dropped out from the treatment group showed about 3 times higher rate of infection. These data support the prevention of bacterial tonsillitis in children by daily consumption of the yogurt prepared with the BIO5 Streptococcus salivarius probiotic.\",\"PeriodicalId\":53704,\"journal\":{\"name\":\"International Journal of Probiotics and Prebiotics\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-08-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Probiotics and Prebiotics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.37290/ijpp2641-7197.15:30-33\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Probiotics and Prebiotics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37290/ijpp2641-7197.15:30-33","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 2

摘要

这项双盲研究旨在验证用唾液链球菌BIO5益生菌菌株制备的酸奶是否可以控制儿童复发性扁桃体炎。为此，患有复发性化脓性链球菌扁桃体炎的儿童在一年内每天食用两种酸奶制剂中的一种。安慰剂组接受用正常酸奶细菌（嗜热链球菌和保加利亚乳杆菌）制备的酸奶，而治疗组接受用唾液链球菌亚种制备的酸乳。salivarius BIO5菌株。在完成研究的儿童中，安慰剂组扁桃体炎的复发率约为89%，而治疗组为12%。此外，退出治疗组的儿童的感染率高出约3倍。这些数据支持通过每天食用用BIO5唾液链球菌益生菌制备的酸奶来预防儿童细菌性扁桃体炎。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Use of Yogurt Prepared with the Probiotic Streptococcus Salivarius BIO5 Strain in the Control of Bacterial Tonsillitis in Children

This double-blinded study aims to verify whether the yogurt prepared with a Streptococcus salivarius BIO5 probiotic strain can control recurrent tonsillitis in children. To this end, children with recurrent Streptococcus pyogenes tonsillitis consumed one of the two yogurt preparations daily for one year. The placebo group received the yogurt prepared with normal yogurt bacteria (Streptococcus thermophilus and Lactobacillus bulgaricus) whereas the treatment group received the yogurt prepared with the S. salivarius subsp. salivarius BIO5 strain. In the children completing the study, the recurrence of tonsillitis was about 89% in the placebo vs. about 12% in the treatment group. Furthermore, the children who dropped out from the treatment group showed about 3 times higher rate of infection. These data support the prevention of bacterial tonsillitis in children by daily consumption of the yogurt prepared with the BIO5 Streptococcus salivarius probiotic.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

International Journal of Probiotics and Prebiotics Nursing-Nutrition and Dietetics

CiteScore

1.20

自引率

0.00%

发文量

期刊介绍： The International journal of Probiotics & Prebiotics publishes on online only in an open access format. This is a broad based international, interdisciplinary peer reviewed scientific journal for critical evaluation of research on prebiotics, probiotics and synbiotics. The major goal of this journal is to provide unbiased scientific data to students, researchers, healthcare providers, and the decision makers in the nutraceutical industry to help make informed choices about prebiotics, probiotics and synbiotics. To this end, the journal will publish original research articles and two types of review articles. First, we will publish a review of preclinical research data coming largely from animal, cell culture and other experimental models. Such data will provide basis for future product development and/or human research initiatives. Second, we will publish a critical evaluation of current human experimental data to help deliver products with medically proven use.